Results 11 to 20 of about 184,173 (204)

Engagement of Fas on Macrophages Modulates Poly I:C induced cytokine production with specific enhancement of IP-10. [PDF]

open access: yesPLoS ONE, 2015
Viral double-stranded RNA (dsRNA) is recognised by pathogen recognition receptors such as Toll-Like Receptor 3 (TLR3) and retinoic acid inducible gene-I (RIG-I), and results in cytokine and interferon production. Fas, a well characterised death receptor,
Caitriona Lyons   +4 more
doaj   +17 more sources

FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy. [PDF]

open access: yesPLoS ONE, 2013
Multiple system atrophy is a parkinsonian neurodegenerative disorder. It is cytopathologically characterized by accumulation of the protein p25α in cell bodies of oligodendrocytes followed by accumulation of aggregated α-synuclein in so-called glial ...
Christine L Kragh   +12 more
doaj   +6 more sources

Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells. [PDF]

open access: yesPLoS ONE, 2018
Over expression of Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) in vascular smooth muscle cells (VSMCs) induces apoptosis and reduces neointima formation occurring after saphenous vein interposition grafting or coronary stenting.
William R English   +5 more
doaj   +7 more sources

Fas induces apoptosis in human coronary artery endothelial cells in vitro [PDF]

open access: yesBMC Cell Biology, 2004
Background Published work suggests that some types of endothelial cells undergo apoptosis in response to ligation of the receptor Fas (CD95, APO1) but other types are resistant.
Wang Rongqi   +5 more
doaj   +3 more sources

Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. [PDF]

open access: yesPLoS ONE, 2009
BACKGROUND: Recent evidence suggests that co-clustering of Fas/CD95 death receptor and lipid rafts plays a major role in death receptor-mediated apoptosis.
Consuelo Gajate   +2 more
doaj   +4 more sources

Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activity. [PDF]

open access: yesPLoS ONE, 2013
Binding of ligand FasL to its receptor Fas triggers apoptosis via the caspase cascade. FasL itself is homotrimeric, and a productive apoptotic signal requires that FasL be oligomerized beyond the homotrimeric state. We generated a series of FasL chimeras
Sophie Daburon   +13 more
doaj   +1 more source

Pro- and anti-apoptotic fate decisions induced by di- and trimeric synthetic cytokine receptors

open access: yesiScience, 2021
Summary: Synthetic strategies to activate cytokine receptors so far only address standard dimeric cytokine receptor assemblies. The 19 ligands of the tumor necrosis factor superfamily (TNFSF), however, form noncovalent trimers and receptor trimerization ...
Sofie Mossner   +2 more
doaj   +1 more source

Necrotic Death Pathway in FAS Receptor Signaling [PDF]

open access: yesThe Journal of Cell Biology, 2000
A caspase 8–deficient subline (JB6) of human Jurkat cells can be killed by the oligomerization of Fas-associated protein with death domain (FADD). This cell death process is not accompanied by caspase activation, but by necrotic morphological changes.
H, Matsumura   +5 more
openaire   +2 more sources

cMet and fas receptor interaction inhibits death-inducing signaling complex formation in endothelial cells [PDF]

open access: yes, 2005
Fas receptor is constitutively expressed on endothelial cells; however, these cells are highly resistant to Fas-mediated apoptosis. In this study, we examined death-inducing signaling complex (DISC) formation in endothelial cells after Fas receptor ...
Brady, H.J.M., Smyth, L.A.
core   +1 more source

The FAS-receptors of apoptosis expression on the medulloblastomas cells

open access: yesUkrainian Neurosurgical Journal, 2005
The Fas-receptor of apoptosis expression on the living medulloblastomas cells was determined. Fas-receptor of apoptosis was expressed on 4–48,8% tumors cells.
Yu. A. Orlov   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy